Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma.

Bandiera S, Billie Bian C, Hoshida Y, Baumert TF, Zeisel MB.

Curr Opin Virol. 2016 Oct;20:99-105. doi: 10.1016/j.coviro.2016.09.010. Review.

PMID:
27741441
2.

Clinical Impact of Viral Load on the Development of Hepatocellular Carcinoma and Liver-Related Mortality in Patients with Hepatitis C Virus Infection.

Noh R, Lee DH, Kwon BW, Kim YH, Kim SB, Song IH.

Gastroenterol Res Pract. 2016;2016:7476231. doi: 10.1155/2016/7476231.

3.

Putting "sticky notes" on the electronic medical record to promote intra-hospital referral of hepatitis B and C virus-positive patients to hepatology specialists: an exploratory study.

Fujii H, Yamaguchi S, Kurai O, Miyano M, Ueda W, Oba H, Aoki T, Enomoto M, Kawada N, Okawa K.

BMC Infect Dis. 2016 Aug 12;16:410. doi: 10.1186/s12879-016-1765-y.

4.

Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma.

Charrière B, Maulat C, Suc B, Muscari F.

World J Hepatol. 2016 Jul 28;8(21):881-90. doi: 10.4254/wjh.v8.i21.881. Review.

5.

Diabetes mellitus and metformin in hepatocellular carcinoma.

Fujita K, Iwama H, Miyoshi H, Tani J, Oura K, Tadokoro T, Sakamoto T, Nomura T, Morishita A, Yoneyama H, Masaki T.

World J Gastroenterol. 2016 Jul 21;22(27):6100-13. doi: 10.3748/wjg.v22.i27.6100. Review.

6.

Antiviral Therapy in Patients with Viral Hepatitis and Hepatocellular Carcinoma: Indications and Prognosis.

Roderburg C, Tacke F, Trautwein C.

Visc Med. 2016 Apr;32(2):121-6. doi: 10.1159/000444990. Review.

PMID:
27413730
7.

Impact of HCV core gene quasispecies on hepatocellular carcinoma risk among HALT-C trial patients.

El-Shamy A, Pendleton M, Eng FJ, Doyle EH, Bashir A, Branch AD.

Sci Rep. 2016 Jun 1;6:27025. doi: 10.1038/srep27025.

8.

Retinoid and carotenoid status in serum and liver among patients at high-risk for liver cancer.

Kataria Y, Deaton RJ, Enk E, Jin M, Petrauskaite M, Dong L, Goldenberg JR, Cotler SJ, Jensen DM, van Breemen RB, Gann PH.

BMC Gastroenterol. 2016 Feb 29;16:30. doi: 10.1186/s12876-016-0432-5.

9.

Alpha-fetoprotein and des-gamma-carboxy-prothrombin at twenty-four weeks after interferon-based therapy predict hepatocellular carcinoma development.

Shakado S, Sakisaka S, Chayama K, Okanoue T, Toyoda J, Izumi N, Matsumoto A, Takehara T, Ido A, Hiasa Y, Yoshioka K, Nomura H, Ueno Y, Seike M, Kumada H.

World J Hepatol. 2015 Nov 28;7(27):2757-64. doi: 10.4254/wjh.v7.i27.2757.

10.

A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma.

Jiang SS, Tang Y, Zhang YJ, Weng DS, Zhou ZG, Pan K, Pan QZ, Wang QJ, Liu Q, He J, Zhao JJ, Li J, Chen MS, Chang AE, Li Q, Xia JC.

Oncotarget. 2015 Dec 1;6(38):41339-49. doi: 10.18632/oncotarget.5463.

12.

How do persistent infections with hepatitis C virus cause liver cancer?

Mitchell JK, Lemon SM, McGivern DR.

Curr Opin Virol. 2015 Oct;14:101-8. doi: 10.1016/j.coviro.2015.09.003. Review.

13.

Hepatocellular Carcinoma in Patients with a Sustained Response to Anti-Hepatitis C Therapy.

D'Ambrosio R, Della Corte C, Colombo M.

Int J Mol Sci. 2015 Aug 19;16(8):19698-712. doi: 10.3390/ijms160819698. Review.

14.

Improved Detection of Hepatocellular Carcinoma by Using a Longitudinal Alpha-Fetoprotein Screening Algorithm.

Tayob N, Lok AS, Do KA, Feng Z.

Clin Gastroenterol Hepatol. 2016 Mar;14(3):469-475.e2. doi: 10.1016/j.cgh.2015.07.049.

PMID:
26260109
15.

Current management of patients with hepatocellular carcinoma.

Kanda T, Ogasawara S, Chiba T, Haga Y, Omata M, Yokosuka O.

World J Hepatol. 2015 Jul 28;7(15):1913-20. doi: 10.4254/wjh.v7.i15.1913.

16.

Natural interferon-beta treatment for patients with chronic hepatitis C in Japan.

Sasaki R, Kanda T, Nakamoto S, Haga Y, Nakamura M, Yasui S, Jiang X, Wu S, Arai M, Yokosuka O.

World J Hepatol. 2015 May 18;7(8):1125-32. doi: 10.4254/wjh.v7.i8.1125. Review.

17.

2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma.

Korean Liver Cancer Study Group (KLCSG).; National Cancer Center, Korea (NCC)..

Korean J Radiol. 2015 May-Jun;16(3):465-522. doi: 10.3348/kjr.2015.16.3.465.

18.

Systematic Review: Impact of Interferon-based Therapy on HCV-related Hepatocellular Carcinoma.

Hsu CS, Chao YC, Lin HH, Chen DS, Kao JH.

Sci Rep. 2015 May 12;5:9954. doi: 10.1038/srep09954. Review.

19.

2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma.

Korean Liver Cancer Study Group (KLCSG).; National Cancer Center, Korea (NCC)..

Gut Liver. 2015 May 23;9(3):267-317. doi: 10.5009/gnl14460.

20.

Improvement of predictive models of risk of disease progression in chronic hepatitis C by incorporating longitudinal data.

Konerman MA, Zhang Y, Zhu J, Higgins PD, Lok AS, Waljee AK.

Hepatology. 2015 Jun;61(6):1832-41. doi: 10.1002/hep.27750.

Items per page

Supplemental Content

Support Center